Gsa Capital Partners LLP Ardelyx, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$3.3 - $4.83 $1.67 Million - $2.45 Million	506,872 Added 1183.64%	549,695 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $138,318 - $211,973	42,823 New	42,823 $145,000
Q4 2022 Feb 13, 2023	BUY	$1.22 - $2.85 $115,784 - $270,479	94,905 Added 17.28%	644,014 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $323,974 - $790,716	549,109 New	549,109 $653,000
Q2 2022 Aug 09, 2022	SELL	$0.51 - $1.17 $300,683 - $689,803	-589,576 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$0.65 - $1.18 $171,406 - $311,168	263,702 Added 80.92%	589,576 $631,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $171,602 - $339,214	199,538 Added 157.94%	325,874 $358,000
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $130,793 - $841,403	102,987 Added 441.08%	126,336 $167,000
Q2 2021 Aug 05, 2021	SELL	$6.55 - $8.98 $44,363 - $60,821	-6,773 Reduced 22.49%	23,349 $177,000
Q1 2021 May 10, 2021	BUY	$6.1 - $7.69 $183,744 - $231,638	30,122 New	30,122 $199,000
Q3 2020 Nov 06, 2020	SELL	$5.25 - $7.08 $190,176 - $256,465	-36,224 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$5.37 - $8.11 $194,522 - $293,776	36,224 New	36,224 $251,000
Q4 2018 Feb 12, 2019	SELL	$1.66 - $4.16 $266,239 - $667,201	-160,385 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$3.75 - $4.65 $603,431 - $748,254	-160,915 Reduced 50.08%	160,385 $698,000
Q2 2018 Aug 09, 2018	BUY	$3.7 - $5.8 $1.19 Million - $1.86 Million	321,300 New	321,300 $1.19 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.